Biobohemia

Biobohemia

Biotechnology, 1 Broadway, Cambridge, , 2142, Massachusetts, United States, 1-10 Employees

biobohemia.com

  • facebook
  • twitter
  • LinkedIn

Who is BIOBOHEMIA

Biobohemia, Inc. is a biotechnology company focused on development of cancer vaccines. Biobohemia's lead technology is cell Antigenic Essence production via proteomics and cell culture te...

Read More

map

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from BIOBOHEMIA

Biobohemia Org Chart and Mapping

Mikhael Goldsblat

Executive Assistant to CEO

Employees
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Biobohemia

Answer: Biobohemia's headquarters are located at 1 Broadway, Cambridge, , 2142, Massachusetts, United States

Answer: Biobohemia's official website is https://biobohemia.com

Answer: Biobohemia's revenue is Under $1 Million

Answer: Biobohemia has 1-10 employees

Answer: Biobohemia is in Biotechnology

Answer: Biobohemia contact info: Phone number: Website: https://biobohemia.com

Answer: Biobohemia, Inc. is a biotechnology company focused on development of cancer vaccines. Biobohemia's lead technology is cell Antigenic Essence production via proteomics and cell culture technology, and which is a deep upgrade of cellular cancer vaccines. Cellular cancer vaccines are among the first types of cancer vaccines to be tested. They use a straightforward approach based on the well-known principle of vaccination vaccinate with what you want to develop protection against. The significant possibilities of such vaccines have been described, but none have yet passed the clinical trial stage. Antigenic essence technology is the revitalization of cellular vaccination, as antigenic essence exhibits all the identifying properties of cancer cells while also allowing for control of composition, purification from ballast substances (cellular 'noise'), and evasion of MHC restrictions. Therefore, antigenic essence technology allows upgrading of already discovered cellular compositions, as well as creation new ones. Our antigenic essence technology platform is behind the development of the potential candidates for cancer vaccine, under the brand name SANTAVAC, that can be tuned against virtually any solid cancer. Our company is progressing the development of both prevention and therapeutic SANTAVAC vaccines.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access